What we can learn about treating CLL from research on other cancers
The multi-cohort SCHOLAR-1 study of refractory aggressive DLBCL
CLL therapy - current status and issues
Overview of the T-SPOT assay for diagnosing tuberculosis and cytomegalovirus
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?